These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 22808086

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
    Promkan M, Liu G, Patmasiriwat P, Chakrabarty S.
    Int J Cancer; 2009 Dec 15; 125(12):2820-8. PubMed ID: 19551867
    [Abstract] [Full Text] [Related]

  • 4. Lin28/let-7/Bcl-xL pathway: the underlying mechanism of drug resistance in Hep3B cells.
    Tian N, Han Z, Li Z, Zhou M, Fan C.
    Oncol Rep; 2014 Sep 15; 32(3):1050-6. PubMed ID: 24970027
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MiR-208a stimulates the cocktail of SOX2 and β-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1.
    Sun X, Jiang S, Liu J, Wang H, Zhang Y, Tang SC, Wang J, Du N, Xu C, Wang C, Qin S, Zhang J, Liu D, Zhang Y, Li X, Wang J, Dong J, Wang X, Xu S, Tao Z, Xu F, Zhou J, Wang T, Ren H.
    Oncotarget; 2015 Oct 20; 6(32):32944-54. PubMed ID: 26460550
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y, Zhang L, Dong Z, Xu H, Yan L, Wang W, Yang Q, Chen C.
    Pathol Res Pract; 2021 Apr 20; 220():153405. PubMed ID: 33756128
    [Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1.
    Wang R, Zhang T, Yang Z, Jiang C, Seng J.
    J Cell Mol Med; 2018 Sep 20; 22(9):4068-4075. PubMed ID: 29971911
    [Abstract] [Full Text] [Related]

  • 9. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.
    Tao WY, Liang XS, Liu Y, Wang CY, Pang D.
    Int J Biol Sci; 2015 Sep 20; 11(1):48-58. PubMed ID: 25552929
    [Abstract] [Full Text] [Related]

  • 10. An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer.
    Sultan M, Nearing JT, Brown JM, Huynh TT, Cruickshank BM, Lamoureaux E, Vidovic D, Dahn ML, Fernando W, Coyle KM, Giacomantonio CA, Langille MGI, Marcato P.
    Mol Oncol; 2021 Aug 20; 15(8):2046-2064. PubMed ID: 33932086
    [Abstract] [Full Text] [Related]

  • 11. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.
    Zheng P, Dong L, Zhang B, Dai J, Zhang Y, Wang Y, Qin S.
    Histochem Cell Biol; 2019 Oct 20; 152(4):281-291. PubMed ID: 31352515
    [Abstract] [Full Text] [Related]

  • 12. ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.
    Hawthorne VS, Huang WC, Neal CL, Tseng LM, Hung MC, Yu D.
    Mol Cancer Res; 2009 Apr 20; 7(4):592-600. PubMed ID: 19372587
    [Abstract] [Full Text] [Related]

  • 13. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
    Clark DW, Mitra A, Fillmore RA, Jiang WG, Samant RS, Fodstad O, Shevde LA.
    Curr Cancer Drug Targets; 2008 Aug 20; 8(5):421-30. PubMed ID: 18690848
    [Abstract] [Full Text] [Related]

  • 14. Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells.
    Liu Y, Li H, Feng J, Cui X, Huang W, Li Y, Su F, Liu Q, Zhu J, Lv X, Chen J, Huang D, Yu F.
    PLoS One; 2013 Aug 20; 8(12):e83083. PubMed ID: 24349438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein.
    Li W, Fan J, Banerjee D, Bertino JR.
    Mol Pharmacol; 1999 Jun 20; 55(6):1088-93. PubMed ID: 10347252
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y, Xu K, Yagüe E.
    Breast Cancer Res Treat; 2015 Jun 20; 151(2):269-80. PubMed ID: 25900794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.